Dennis Selkoe, MD: Current Challenges in Alzheimer Disease and Hope for the Future
Selkoe spoke to a number of topics in the Alzheimer space, including the challenges in the field and his excitement for the future.
Dennis Selkoe, MD: Crenezumab Significantly Reduces Aβ Oligomers in CSF
The results conclude that treatment with crenezumab was associated with a consistent decrease in Aβ oligomer levels in the CSF.
2 Clarke Drive Cranbury, NJ 08512